The event involved a 30 cm (12") add-on set w/4 check valves, vented cap where the customer reported a maladjustment at the tap junction of the device chemo tree.Disconnection of one valve.Risk of cytotoxic spill for patient and healthcare provider.The event happened around 12:00 pm.The status of the product at the time of the event is during chemotherapy.There was patient involvement ((b)(6) with file number : (b)(4)) and unknown adverse event/human harm.Bedridden patient, calm before, during and after the event.To note a hemorrhage in the morning, inducing an emergency ct angiogram for etiology research while the patient was undergoing treatment.The stretcher bearer would have been exposed to the cytotoxic (the exposed area was washed abundantly with water, but it is not known if he realized a non-compliance on his side, he was no longer there at the arrival of the reporter).No need for medical intervention for the stretcher bearer.The medication involved is 5-fu.In terms of impact on the patient, no direct harm but a dose not fully received.No medical intervention was necessary, but the pharmacist was called to keep him informed (continuation of the chemo in progress because no precise data on the dose not received).There was a delay in administration of approximately 1 hour (time of trivorex protocol carried out in the corridor where the cytotoxic was spilled and reinstallation of the patient in the room).The treatment has been resumed but part of the dose was lost.No default noted by the nurse the day before the event on the device.No cut, no hole, no tear on the device.
|